Prophylactic Nepafenac and Ketorolac Versus Placebo in Patients Undergoing Cataract Surgery
Status:
Completed
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
Assess prophylactic efficacy of topical non-steroidal anti-inflammatory drops in preventing
macular edema. Patient undergoing uncomplicated cataract surgery will be enrolled and
randomized to nepafenac, ketorolac, or placebo. Follow-up will occur at 1 month with ocular
coherence tomography (OCT).